ScienceDaily: Top Health News |
- MRI detects early effects of chemotherapy on children's hearts
- Duck genome provides new insight into fighting bird flu
- 3-D map of blood vessels in cerebral cortex holds suprises
- Scientists map process by which brain cells form long-term memories
- Interferon-beta aids balance and movement in mice with spinocerebellar ataxia 7; first in vivo study of the treatment for this condition shows significant physical improvement
- Scientists identify potential drug target for treatment-resistant anemias
MRI detects early effects of chemotherapy on children's hearts Posted: 09 Jun 2013 07:08 PM PDT MRI scans of children who have had chemotherapy can detect early changes in their hearts. |
Duck genome provides new insight into fighting bird flu Posted: 09 Jun 2013 04:57 PM PDT The duck genome consortium has completed the genome sequencing and analysis of the duck (Anas platyrhynchos), one principal natural host of influenza A viruses, which caused a new epidemic in China since this February. This work reveals some noteworthy conclusions and provides an invaluable resource for unraveling the interactive mechanisms between the host and influenza viruses. |
3-D map of blood vessels in cerebral cortex holds suprises Posted: 09 Jun 2013 04:57 PM PDT Blood vessels within a sensory area of the mammalian brain loop and connect in unexpected ways, a new map has revealed. |
Scientists map process by which brain cells form long-term memories Posted: 09 Jun 2013 04:57 PM PDT Scientists have deciphered how a protein called Arc regulates the activity of neurons -- providing much-needed clues into the brain's ability to form long-lasting memories. These findings also offer newfound understanding as to what goes on at the molecular level when this process becomes disrupted. |
Posted: 09 Jun 2013 04:56 PM PDT The first in vivo trial of the use of interferon-beta in a mouse model of the group of fatal diseases known as spinocerebellar ataxia has shown that its use can significantly improve their physical condition and control symptoms. Researchers believe that their results show that a clinical trial in humans is merited. |
Scientists identify potential drug target for treatment-resistant anemias Posted: 09 Jun 2013 04:56 PM PDT Researchers have identified a key target protein of glucocorticoids, the drugs that are used to increase red blood cell production in patients with certain types of anemia, including those resulting from trauma, sepsis, malaria, kidney dialysis, and chemotherapy. The discovery could spur development of drugs capable of increasing this protein's production and thus increased numbers of red blood cells without causing the severe side effects associated with glucocorticoids. |
You are subscribed to email updates from ScienceDaily: Top Health News To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google Inc., 20 West Kinzie, Chicago IL USA 60610 |
No comments:
Post a Comment